JJ
Jaganathan Jayaseelan
About Jaganathan Jayaseelan
Data last updated:
Jaganathan Jayaseelan is a Director at Saimirra Innopharm Private Limited (since 2012), Director at Nuray Chemicals Private Limited (since 2012) and Director at Inventz Life Sciences Private Limited (since 2017), and holds 6 more current directorships. The companies operate in Pharma, E-Commerce and Infrastructure and Utilities. The 7 current companies with reported revenue have a combined latest revenue of ₹268 Cr; the largest is Saimirra Innopharm Private Limited at ₹133 Cr (FY 2025). Earlier, Jaganathan Jayaseelan was a Director at Lifespan Wellness Private Limited (2018–2023) and Director at Vendan Technologies Private Limited (2017–2022) and 8 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Jul 2012 | 2000 | ₹133 Cr (FY 2025) | Active | |
| Director | 14 Jun 2012 | 2012 | ₹122 Cr (FY 2025) | Active | |
| Director | 23 Mar 2017 | 2017 | ₹5.52 Cr (FY 2024) | Active | |
| Director | 27 Mar 2018 | 2018 | ₹4.89 Cr (FY 2024) | Active | |
| Director | 08 Feb 2008 | 2008 | ₹1.94 Cr (FY 2023) | Active | |
| Managing Director | 11 Jan 2023 | 2023 | ₹61.2 Lakh (FY 2025) | Active | |
| Director | 31 Jul 2015 | 2015 | ₹32.6 Lakh (FY 2023) | Active | |
| Director | 01 Nov 2019 | 1992 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Sep 2018 | 2012 | ₹2.80 Cr (FY 2022) | Active | |
| Director | 18 Dec 2017 | 2017 | Active | ||
| Director | 21 Aug 2017 | 2017 | ₹5.57 Cr (FY 2021) | Active | |
| Director | 01 Mar 2017 | 2017 | ₹1,000 (FY 2022) | Active | |
| Director | 15 May 2009 | 1982 | ₹1,462 Cr (FY 2025) | Active | |
| Director | 28 Aug 2020 | 2016 | ₹1.04 Cr (FY 2025) | Active | |
| Director | 04 Jul 2001 | 2001 | ₹63.6 Lakh (FY 2019) | Amalgamated | |
| Additional Director | 16 Mar 2015 | 2011 | ₹2.46 Cr (FY 2017) | Active | |
| Director | 24 Jul 2009 | 2009 | ₹30.87 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Jaganathan Jayaseelan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Jaganathan Jayaseelan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jaganathan Jayaseelan
Jaganathan Jayaseelan currently holds 9 directorships: Saimirra Innopharm Private Limited (Director, since 18 Jul 2012, revenue ₹133 Cr (FY 2025)); Nuray Chemicals Private Limited (Director, since 14 Jun 2012, revenue ₹122 Cr (FY 2025)); Inventz Life Sciences Private Limited (Director, since 23 Mar 2017, revenue ₹5.52 Cr (FY 2024)); Hibrow Healthcare Private Limited (Director, since 27 Mar 2018, revenue ₹4.89 Cr (FY 2024)); Clan Laboratories Private Limited (Director, since 08 Feb 2008, revenue ₹1.94 Cr (FY 2023)); and 4 more.
Jaganathan Jayaseelan was first appointed on 04 Jul 2001 as Director at Aindro Pharmaceuticals Private Limited. The most recent appointment on record is 11 Jan 2023 at Tindivanam Pharma Park Association.
The 7 current companies of Jaganathan Jayaseelan that report revenue have a combined latest revenue of ₹268 Cr: Saimirra Innopharm Private Limited ₹133 Cr (FY 2025); Nuray Chemicals Private Limited ₹122 Cr (FY 2025); Inventz Life Sciences Private Limited ₹5.52 Cr (FY 2024); Hibrow Healthcare Private Limited ₹4.89 Cr (FY 2024); Clan Laboratories Private Limited ₹1.94 Cr (FY 2023); and 2 more.
Jaganathan Jayaseelan held 10 earlier board appointments: Lifespan Wellness Private Limited (Director, 01 Sep 2018 to 31 May 2023); Vendan Technologies Private Limited (Director, 18 Dec 2017 to 20 Jun 2022); Tavagraha Health Solutions Private Limited (Director, 21 Aug 2017 to 02 Nov 2022); Nutrimed Life Sciences Private Limited (Director, 01 Mar 2017 to 21 Mar 2018); Par Formulations Private Limited (Director, 15 May 2009 to 17 Feb 2012); and 5 more.
The current boards of Jaganathan Jayaseelan's companies include Abhishek Jain (Saimirra Innopharm Private Limited), Anushree Manmohan Chandak (Saimirra Innopharm Private Limited), Ayyavu Rajavel (Saimirra Innopharm Private Limited), Bernice Sugirtha (Saimirra Innopharm Private Limited), Shanmugam Muthusamy (Saimirra Innopharm Private Limited), Thanigainathan Thirumurugan (Saimirra Innopharm Private Limited), among others.